This playbook explains how to take a proactive approach to meeting new DSCSA guidelines while maintaining supply chain integrity.
With the final deadline for the Drug Supply Chain Security Act (DSCSA) looming large, today’s biopharma companies are working hard to meet the heightened requirements and maintain the integrity of their pharmaceutical supply chains.
To ensure all supply chain stakeholders are prepared for the transition, the time is now for companies to have the right technology, infrastructure, and processes in place.
This user-friendly playbook offers a concise overview of the DSCSA and outlines how biopharma companies can achieve seamless compliance in their warehouses. It covers:
Offered Free by: BioPharma Dive's studioID and Tecsys
See All Resources from: BioPharma Dive's studioID and Tecsys
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.